Company profile ONTX
There is not enough data for Onconova Therapeutics -stock -company to provide analysis
There is not enough data for Onconova Therapeutics -stock -company to provide correlation calculation
There is not enough data for Onconova Therapeutics -stock -company to provide analysis
There is not enough data for narazaciclib clinical trials to provide analysis
There is not enough data for narazaciclib clinical trials to provide correlation calculation
There is not enough data for narazaciclib clinical trials to provide analysis
There is not enough data for rigosertib cancer treatment to provide analysis
There is not enough data for rigosertib cancer treatment to provide correlation calculation
There is not enough data for rigosertib cancer treatment to provide analysis
There is not enough data for K-Ras mutated lung cancer treatment to provide analysis
There is not enough data for K-Ras mutated lung cancer treatment to provide correlation calculation
There is not enough data for K-Ras mutated lung cancer treatment to provide analysis
There is not enough data for recessive dystrophic epidermolysis bullosa treatment to provide analysis
There is not enough data for recessive dystrophic epidermolysis bullosa treatment to provide correlation calculation
There is not enough data for recessive dystrophic epidermolysis bullosa treatment to provide analysis
There is not enough data for HanX Biopharmaceuticals collaboration to provide analysis
There is not enough data for HanX Biopharmaceuticals collaboration to provide correlation calculation
There is not enough data for HanX Biopharmaceuticals collaboration to provide analysis
There is not enough data for Onconova headquarters to provide analysis
There is not enough data for Onconova headquarters to provide correlation calculation
There is not enough data for Onconova headquarters to provide analysis
After 81 days of this quarter the interest is at 513.0. Based on that we can calculate that during remaining 11 days it will total up to 583.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | 67 | 634 846.3% QoQ |
| 2019 | 424 -33.1% QoQ | 401 -5.4% QoQ | 376 461.2% YoY -6.2% QoQ | 658 3.8% YoY 75.0% QoQ |
| 2020 | 483 13.9% YoY -26.6% QoQ | 466 16.2% YoY -3.5% QoQ | 494 31.4% YoY 6.0% QoQ | 767 16.6% YoY 55.3% QoQ |
| 2021 | 551 14.1% YoY -28.2% QoQ | 556 19.3% YoY 0.9% QoQ | 555 12.3% YoY -0.2% QoQ | 860 12.1% YoY 55.0% QoQ |
| 2022 | 680 23.4% YoY -20.9% QoQ | 575 3.4% YoY -15.4% QoQ | 563 1.4% YoY -2.1% QoQ | 866 0.7% YoY 53.8% QoQ |
| 2023 | 699 2.8% YoY -19.3% QoQ | 694 20.7% YoY -0.7% QoQ | 513 -8.9% YoY -26.1% QoQ | - |
The average 5 years interest of was 45.7 per week. The last year interest of compared to the last 5 years has changed by 20.53%. The interest for is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 55.68%.